APO RESEARCH · REPORT
PNH and aHUS
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
Product & engineering
Understand the product.
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
Selected research
Industry Growth & Trends
Global PNH and aHUS Industry Growth and Trends Forecast to 2032
Market perspective
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
According to APO Research, the global PNH and aHUS market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global PNH and aHUS market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The PNH and aHUS market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global PNH and aHUS market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to PNH and aHUS.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global PNH and aHUS market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
PNH and aHUS Market by Company
Alexion Pharmaceuticals
Alnylam Pharmaceuticals
Omeros Corporation
PNH and aHUS Segment by Type
Soliris
Ultomiris
PNH and aHUS Segment by Application
PNH
aHUS
PNH and aHUS Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PNH and aHUS market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PNH and aHUS and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PNH and aHUS.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of PNH and aHUS companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Soliris
- Ultomiris
Applications
- PNH
- aHUS
Companies covered
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Omeros Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global PNH and aHUS Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global PNH and aHUS Market Size by Region (2021-2032)
- 1.4.1 Global PNH and aHUS Market Size by Region (2021-2026)
- 1.4.2 Global PNH and aHUS Market Size by Region (2027-2032)
- 1.5 Key Regions PNH and aHUS Market Size (2021-2032)
- 1.5.1 North America PNH and aHUS Market Size Growth Rate (2021-2032)
- 1.5.2 Europe PNH and aHUS Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific PNH and aHUS Market Size Growth Rate (2021-2032)
- 1.5.4 South America PNH and aHUS Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa PNH and aHUS Market Size Growth Rate (2021-2032)
2 PNH and aHUS Market by Type
- 2.1 Type Introduction
- 2.1.1 Soliris
- 2.1.2 Ultomiris
- 2.2 Global PNH and aHUS Market Size by Type
- 2.2.1 Global PNH and aHUS Market Size Overview by Type (2021-2032)
- 2.2.2 Global PNH and aHUS Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global PNH and aHUS Market Size Forecasted by Type (2027-2032)
- 2.3 Global PNH and aHUS Market Size by Regions
- 2.3.1 North America PNH and aHUS Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe PNH and aHUS Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific PNH and aHUS Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America PNH and aHUS Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa PNH and aHUS Market Size Breakdown by Type (2021-2026)
3 PNH and aHUS Market by Application
- 3.1 Type Introduction
- 3.1.1 PNH
- 3.1.2 aHUS
- 3.2 Global PNH and aHUS Market Size by Application
- 3.2.1 Global PNH and aHUS Market Size Overview by Application (2021-2032)
- 3.2.2 Global PNH and aHUS Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global PNH and aHUS Market Size Forecasted by Application (2027-2032)
- 3.3 Global PNH and aHUS Market Size by Regions
- 3.3.1 North America PNH and aHUS Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe PNH and aHUS Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific PNH and aHUS Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America PNH and aHUS Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa PNH and aHUS Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 PNH and aHUS Industry Trends
- 4.2 PNH and aHUS Industry Drivers
- 4.3 PNH and aHUS Industry Opportunities and Challenges
- 4.4 PNH and aHUS Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by PNH and aHUS Revenue (2021-2026)
- 5.2 Global PNH and aHUS Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global PNH and aHUS Key Company Headquarters & Area Served
- 5.4 Global PNH and aHUS Company, Product Type & Application
- 5.5 Global PNH and aHUS Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global PNH and aHUS Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 PNH and aHUS Players Market Share by Revenue in 2025
- 5.6.3 2025 PNH and aHUS Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Alexion Pharmaceuticals
- 6.1.1 Alexion Pharmaceuticals Company Information
- 6.1.2 Alexion Pharmaceuticals Business Overview
- 6.1.3 Alexion Pharmaceuticals PNH and aHUS Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Alexion Pharmaceuticals PNH and aHUS Product Portfolio
- 6.1.5 Alexion Pharmaceuticals Recent Developments
- 6.2 Alnylam Pharmaceuticals
- 6.2.1 Alnylam Pharmaceuticals Company Information
- 6.2.2 Alnylam Pharmaceuticals Business Overview
- 6.2.3 Alnylam Pharmaceuticals PNH and aHUS Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Alnylam Pharmaceuticals PNH and aHUS Product Portfolio
- 6.2.5 Alnylam Pharmaceuticals Recent Developments
- 6.3 Omeros Corporation
- 6.3.1 Omeros Corporation Company Information
- 6.3.2 Omeros Corporation Business Overview
- 6.3.3 Omeros Corporation PNH and aHUS Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Omeros Corporation PNH and aHUS Product Portfolio
- 6.3.5 Omeros Corporation Recent Developments
7 North America
- 7.1 North America PNH and aHUS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America PNH and aHUS Market Size by Country (2021-2026)
- 7.3 North America PNH and aHUS Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe PNH and aHUS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe PNH and aHUS Market Size by Country (2021-2026)
- 8.3 Europe PNH and aHUS Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific PNH and aHUS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific PNH and aHUS Market Size by Country (2021-2026)
- 9.3 Asia-Pacific PNH and aHUS Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America PNH and aHUS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America PNH and aHUS Market Size by Country (2021-2026)
- 10.3 South America PNH and aHUS Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa PNH and aHUS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa PNH and aHUS Market Size by Country (2021-2026)
- 11.3 Middle East & Africa PNH and aHUS Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst